Etoricoxib Intermediate

We are leading manufacturer and exporter of Etoricoxib Intermediate and our product is made up of good quality. Etoricoxib is a COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. About the Company GST Registration Date: 2017 Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 5 - 25 Cr company-description: Incorporated in the year 2007, under the visionary Mr. Sanjay Totre, today Yashica Pharmaceuticals has evolved as a pioneer in pharmaceutical drugs worldwide. The quality range of our products includes Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates. These are manufactured as per the international standards & meet all regulation of pharmaceutical and chemical industries. With the help of our sound manufacturing facility, we are able to prepare a highly effective range of products. Our professional approach has helped us in maintaining the trust of our clients.